Ahmed Temirak

7PUBLICATIONS
20CO-AUTHORS
Molecular targetsCheminformatics and quantitative structure-activity relationshipsBiomolecular modelling and designBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 09, 2025
Targeting apoptotic pathways in cancer: design, synthesis, and molecular docking studies of 1,3,5-trisubstituted-1H-pyrazole derivatives with Bcl-2 inhibition and DNA damage potential.

Ahmed Temirak, Ahmed A F Soliman, Mohamed B Shalaby

|Jul 16, 2024
Barbiturate-sulfonate hybrids as potent cholinesterase inhibitors: design, synthesis and molecular modeling studies.

Asmaa F Kassem, Mohamed A Omar, Ahmed Temirak

|Nov 23, 2023
Hydrazone-sulfonate hybrids as potential cholinesterase inhibitors: design, synthesis and molecular modeling simulation.

Mohamed A Omar, Riham A El-Shiekh, Dina H Dawood

|Jun 12, 2023
Therapeutic potential of 1,3,4-oxadiazoles as potential lead compounds for the treatment of Alzheimer's disease.

Saira Naseem, Ahmed Temirak, Aqeel Imran

|Nov 11, 2022
Preliminary Evidence of the Potent and Selective Adenosine A2B Receptor Antagonist PSB-603 in Reducing Obesity and Some of Its Associated Metabolic Disorders in Mice.

Magdalena Kotańska, Anna Dziubina, Małgorzata Szafarz

|Jun 24, 2022
Irreversible Antagonists for the Adenosine A2B Receptor.

Ahmed Temirak, Jonathan G Schlegel, Jan H Voss

Pageof 2

Frequent Collaborators

3 joint publications

Christa E Müller

2 joint publications

Aladdin M Srour

2 joint publications

Riham A El-Shiekh

2 joint publications

Mohamed A Omar